Efalizumab Clinical Trials

• Study of the Drug Efalizumab (Raptiva), for Adult Patients with Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00115076 - Active, not recruiting
  Psoriasis
  
• Efalizumab for Eczema
  ClinicalTrials.gov Identifier: NCT00146003 - Active, not recruiting
  Atopic Dermatitis
  
• Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00133107 - Recruiting
  Oral Lichen Planus
  
• Evaluate Whether a Course of Methotrexate in Psoriasis Patients Treated With Efalizumab is Safe and Increases Efficacy
  ClinicalTrials.gov Identifier: NCT00368654 - Active, not recruiting
  Psoriasis
  
• Islet Transplantation Using Efalizumab
  ClinicalTrials.gov Identifier: NCT00276250 - Recruiting
  Type 1 Diabetes Mellitus
  
• RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization
  ClinicalTrials.gov Identifier: NCT00402818 - Recruiting
  Plaque Psoriasis
  
• Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
  ClinicalTrials.gov Identifier: NCT00510536 - Recruiting
  Arthritis; Arthralgia
  
• Open-Label Assessment of the Efficacy & Safety of Efalizumab in the Treatment of Mod-Severe Hidradenitis Suppurativa
  ClinicalTrials.gov Identifier: NCT00134134 - Completed
  Hidradenitis Suppurativa
  
• A Multicentre, Open Label Ph 3b/4 Study of Subcutaneously Admin. Efalizumab (Adult Patients) With Moderate to Severe Chronic Psoriasis Failed to Respond to, or Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Incl. Cyclosporine, M
  ClinicalTrials.gov Identifier: NCT00249808 - Active, not recruiting
  Candidates for Systemic Therapy for Psoriasis
  
• Efalizumab to Treat Uveitis
  ClinicalTrials.gov Identifier: NCT00280826 - Recruiting
  Uveitis; Intraocular Inflammatory Diseases
  
• Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00472082 - Recruiting
  Kidney Transplantation; Chronic Kidney Failure
  
• Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00184366 - Recruiting
  Plaque Psoriasis
  
• Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
  ClinicalTrials.gov Identifier: NCT00489216 - Recruiting
  Graft Versus Host Disease
  
• A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis
  ClinicalTrials.gov Identifier: NCT00302445 - Completed
  Plaque Psoriasis
  
• A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies
  ClinicalTrials.gov Identifier: NCT00338143 - Completed
  Psoriasis
  
• A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet
  ClinicalTrials.gov Identifier: NCT00312026 - Completed
  Psoriasis
  
• A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00382512 - Completed
  Plaque Psoriasis
  
• A Study to Evaluate Raptiva in Adults with Moderate to Severe Plaque Psoriasis Who are Candidates for Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00109317 - Completed
  Psoriasis
  
• A Study to Evaluate Raptiva in Combination with Topical Psoriasis Therapies
  ClinicalTrials.gov Identifier: NCT00096980 - Completed
  Psoriasis
  
• Efalizumab for Moderate to Severe Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00226057 - Completed
  Dermatitis, Atopic
  
• Safety and efficacy of a monoclonal antibody for treatment of rheumatoid arthritis.
  ClinicalTrials.gov Identifier: NCT00034203 - Completed
  Rheumatoid Arthritis
  
• A Study to Evaluate the Safety of Raptiva in Adults with Plaque Psoriasis Previously Enrolled in Study ACD2600g
  ClinicalTrials.gov Identifier: NCT00096603 - Completed
  Psoriasis
  
• A Study to Evaluate Raptiva in Adults with Plaque Psoriasis Previously Enrolled in Study ACD2390g
  ClinicalTrials.gov Identifier: NCT00109252 - Completed
  Psoriasis
  
• Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00051662 - Completed
  Psoriatic Arthritis
  
• Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis
  ClinicalTrials.gov Identifier: NCT00442650 - Completed
  Moderate to Severe Psoriasis